Medicaments administration into the subtenon eye space in treatment of anterior ischemic neuropathy.

V. N. Sakovich, E. M. Grechka, M. E. Stepakhina, Е. А. Derbina, N. V. Guzenko

Abstract


In spite of treatment provided inanterior ischemic neuropathy, a prognosis for visual functions is poor and depends on severity of affection ofvascular system of the body. We have studied the exposure to cortexin and diprospan in subtenon administration on the eye hemodynamics in 18 patients experiencing anterior ischemic neuropathy(18 eyes) who have been treated operatively (administration of cortexin and diprospan into the subtenon space of the affected eye) against the background of complex conservative prevention. The control group was constituted of 16 patients (16 eyes) who have not been treated operatively. As a result of provided treatment the patients of the basic group showed increase of vision acuity, field of view limits and eye ground state. 


Keywords


anterior ischemic neuropathy; subtenon eye space; treatment

Full Text:

PDF

References


Bishele NA. [Vasoactive Preparations are in Treatment of Ischemic Diseases of Retina]. Russian Me­dical Journal. 2000;1:24-29. Russian.

Eliseeva TO. [Methods of Treatment of the Ische­mic States of Visual Nerve and Retina]. Clinical Ophthal­mology. 2002;3:106-11. Russian.

Eremenko АI. [Basic forms of vascular optical neuropathy (clinic, diagnostics, treatment): dissertation thesis of the doctor of medical sciences: special 14.00.08] Odesa; 1991. Russian.

Kansky JJ. [Diseases of Eye fundus]. Мoskva. 2008;231-48. Russian.

Kiselyova ТN. [Differentiated conservative treatment of an eye ischemic syndrome]. Vestnik ophthal­mology. 2001;5:27-29. Russian.

Zavgorodnya NG, Sarjevska LЕ, Bezdene­zhna ОО, et al. [Eye ischemic syndrome: modern prin­ciples of diagnosis and treatment]. Educational metho­dical manual. Zakarpatye; 2012. Ukrainian.

Chung SM, Gay CA, McCrary JA. Nonarteritic anterior ischemic optic neuropathy. The impact of tobacco use. Ophthalmology. 1994;101:779-82.

Hayreh SS. Factors influencing blood flow in the optic nerve head. J. Glaucoma. 1997;13:412-25.


GOST Style Citations


1.       Бишеле Н.А. Вазоактивные препараты в ле­чении ишемических заболеваний сетчатки / Н.А. Бишеле, Т.О. Елисеева // Рус. мед. журнал. – 2000- № 1 – С. 24-29.

2.       Елисеева Т.О. Методы лечения ишемических состояний зрительного нерва и сетчатки / Т.О. Ели­сеева, А.В. Свирин // Клинич. офтальмология. –2002. – № 3. – С. 106-111.

3.       Еременко А.И.Основные формы сосудистых оптических нейропатий (клиника, диагностика, лече­ние): автореф. дис. на соискание учен. степени д-ра мед. наук: спец. 14.00.08 / А.И. Еременко. – Одесса, 1991. – 29 с.

4.       Кански Дж. Дж. Заболевания глазного дна / Дж.Дж. Кански; под ред. С.Э.Аветисова. – Москва, 2008. – 53 с.

5.       Киселева Т.Н. Дифференцированное консерва­тивное лечение глазного ишемичного синдрома / Т.Н. Киселева, Л.Н. Тарасова // Вестник офтальмо­логии. – 2001. – № 5 – С. 27-29.

6.       Очний ішемічний синдром, сучасні принципи діагностики та лікування: навч.-метод. посібник / Н.Г. Завгородня, Л.Е. Саржевська, О.О. Безденежна [та ін.]. – Закарпаття, 2012. – 248 с.

7.       Chung S.M. Nonarteritic anterior ischemic optic neuropathy. The impact of tobacco use / S.M. Chung,  C.A. Gay, J.A. McCrary // Ophthalmology. – 1994. – Vol. 101. – P. 779-782.

8.       Hayreh S.S. Factors influencing blood flow in the optic nerve head / S.S.  Hayreh // J. Glaucoma. – 1997. – N 13. – P. 412-425.





DOI: https://doi.org/10.26641/2307-0404.2017.1.100899

Refbacks

  • There are currently no refbacks.

Comments on this article

View all comments